Karihtala and colleagues [13] observed that staining for PRDX2 and PRDX6 was negative in half of breast cancer cases, whereas PRDX1, PRDX3, PRDX4 and PRDX5 showed stronger expression levels. Here, PRDX4 is linked to breast carcinoma.